Product Categories
| Country: | China |
|---|---|
| Tel: | 177-54423994 |
| Mobile: | 17754423994 |
| E-mail: | 2853530910@QQ.com |
| QQ: | 2853530910 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| N-Benzylcyclohexanamine | C13H19N | 4383-25-9 | Details |
| Clarithromycin EP Impurity I | C30H55NO10 | 118058-74-5 | Details |
| (Alphas)-alpha-Aminobenzenebutanoyl-L-leucyl-L-phenylalanine methyl ester mono(trifluoroacetate) | C28H36F3N3O5 | 868539-99-5 | Details |
| (3-Chlorophenyl)hydrazonomalononitrile | C9H5ClN4 | 555-60-2 | Details |
| Disperse Yellow 7 | C19H16N4O | 6300-37-4 | Details |
| CD38 inhibitor 1 | C22H27N3O3S | 1700637-55-3 | Details |
| MC180295 | C17H18N4O3S | 2237942-08-2 | Details |
| BTdCPU | C13H8Cl2N4OS | 1257423-87-2 | Details |
| AP1867-3-(Methoxyethylamine) | C38H50N2O9 | 2127390-15-0 | Details |
| 1-Myristoyl-2-Stearoylphosphatidylcholine | C40H80NO8P | 76343-22-1 | Details |
| Befiradol | C20H22ClF2N3O | 208110-64-9 | Details |
| SJB3-019A | C16H8N2O3 | 2070015-29-9 | Details |
| Deferasirox Impurity 2 | C23H17N3O6 | 1395346-29-8 | Details |
| Etifenin | C16H22N2O5 | 63245-28-3 | Details |
| Methyl 8-(tert-butyl)-6-chloroimidazo[1,2-b]pyridazine-2-carboxylate | C12H14ClN3O2 | 1690176-75-0 | Details |
| E3 Ligase Ligand-Linker Conjugates 18 | C19H20N6O6 | 2098488-36-7 | Details |
| LOC-14 | C16H19N3O2S | 877963-94-5 | Details |
| PLX5622 | C21H19F2N5O | 1303420-67-8 | Details |
| Nigericin sodium salt | C40H69NaO11 | 28643-80-3 | Details |
| N-Desmethyl Clarithromycin | C37H67NO13 | 101666-68-6 | Details |
| Folic Acid Impurity C | C19H19N7O6 | 47707-78-8 | Details |
| Folic acid Impurity E | C26H24N12O7 | 1391068-26-0 | Details |
| Theliatinib | C25H26N6O2 | 1353644-70-8 | Details |
| RG7800 | C24H28N6O | 1449598-06-4 | Details |
| Bergamotine | C21H22O4 | 7380-40-7 | Details |
| BPK-29 | C26H32ClN3O3 | 2143467-62-1 | Details |
| JND3229 | C33H41ClN8O2 | 2260886-64-2 | Details |
| LY2444296 | C24H22F2N2O2 | 1346133-11-6 | Details |
| GSK3145095 | C20H17F2N5O2 | 1622849-43-7 | Details |
| GLP-1 receptor agonist 5 | C50H47Cl2N3O6 | 1246826-07-2 | Details |
| 3-(4-Methylpiperazin-1-ylmethyl)benzoic acid | C13H18N2O2 | 514209-42-8 | Details |
| 2-HBA | C17H14O3 | 131359-24-5 | Details |
| Pristinamycin IIA | C28H35N3O7 | 21411-53-0 | Details |
| Fmoc-Ser-(GalNAc(Ac)3-alpha-D)-OH | C32H36N2O13 | 120173-57-1 | Details |
| PF-06882961 | C31H30FN5O4 | 2230198-02-2 | Details |
| AP1867 | C38H47NO11 | 195514-23-9 | Details |
| VP3.15 dihydrobromide | C20H23BrN4OS | 1281681-33-1 | Details |
| GS-4361 | C26H17F3N4O | 2291164-02-6 | Details |
| Dual Specificity Protein Phosphatase 1/6 Inhibitor | C22H23NO | 15982-84-0 | Details |
| ML401 | C20H20BrClN2O | 1597489-14-9 | Details |
| Ethyl 5-nitroindole-2-carboxylate | C11H10N2O4 | 16732-57-3 | Details |
| Rilapladib | C40H38F5N3O3S | 412950-08-4 | Details |
| SNAP 94847 hydrochloride | C29H32F2N2O2 | 487051-12-7 | Details |
| Clarithromycin EP Impurity N | C38H67NO12 | 144604-03-5 | Details |
| Clarithromycin EP Impurity O | C39H72N2O13 | 127252-80-6 | Details |
| C-178 | C17H10N2O5 | 329198-87-0 | Details |
| USP25 and 28 inhibitor AZ-1 | C17H16BrF4NO2 | 2165322-94-9 | Details |
| Pranoprofen Impurity 5 | C16H15NO3 | 145986-74-9 | Details |
| D-I03 | C23H36N6S | 688342-78-1 | Details |
| FEN1-IN-1 | C15H12N2O5S | 824983-91-7 | Details |
| AHR antagonist 1 | C20H17ClFN3O3 | 2162982-11-6 | Details |
| S29434 | C21H18N4O3 | 874484-20-5 | Details |
| FKBP12 Ligand | C38 H47 N O11 | 2230613-03-1 | Details |
| Entadamide-A-β-D-glucopyranoside | C12H21NO7S | 138916-58-2 | Details |
| Fosaprepitant Impurity 31 | C20H18F7NO2 | 1185503-48-3 | Details |
| Tert-butyl 4-chlorobutanoate | C8H15ClO2 | 3153-32-0 | Details |
| (3S)-3-amino-2-hydroxy-5-methylhexanoicacid | C7H15NO3 | 318464-20-9 | Details |
| SAR348830 | C28H32FN5O3S | 1462949-64-9 | Details |
| MZ 1 | C49H60ClN9O8S2 | 1797406-69-9 | Details |
| 3-Hydroxy-2,4,6-triiodobenzoic acid | C7H3I3O3 | 53279-72-4 | Details |
| Shield-1 | C42H56N2O10 | 914805-33-7 | Details |
| CINPA1 | C23H29N3O3 | 102636-74-8 | Details |
| GW284543 | C23H20N2O3 | 790186-68-4 | Details |
| H3B-6545 | C30H29F4N5O2 | 2052130-80-8 | Details |
| OXFBD04 | C17H16N2O3 | 2231747-03-6 | Details |
| N-Benzylguanidinium acetate | C8H11N3 | 2211-57-6 | Details |
| Pristinamycin IA | C45H54N8O10 | 3131-03-1 | Details |
| MRS1754 | C26H26N6O4 | 264622-58-4 | Details |
| 1-[({1-[(4-Methoxyphenyl)sulfonyl]piperidin-4-yl}carbonyl)oxy]pyrrolidine-2,5-dione | C17H20N2O7S | 903853-23-6 | Details |
| Ethyl 5-amino-1H-indole-2-carboxylate | C11H12N2O2 | 71086-99-2 | Details |
| JMS-17-2 | C25H26ClN3O | 1380392-05-1 | Details |
| IDF-11774 | C23H32N2O2 | 1429054-28-3 | Details |
| SATA Protein Modifier | C8H9NO5S | 76931-93-6 | Details |
| Glumetinib | C21H17N9O2S | 1642581-63-2 | Details |
| GNE-6640 | C20H18N4O | 2009273-67-8 | Details |
| Belvarafenib | C23H16ClFN6OS | 1446113-23-0 | Details |
| 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, (2R)-,monomethanesulfonate | C18H30N2O4S | 856865-74-2 | Details |
| MSC1094308 | C29H29F3N2 | 2219320-08-6 | Details |
| NDI-091143 | C20H14ClF2NO5S | 2375840-87-0 | Details |
| MMP-9 Inhibitor II | C27H33N3O5S | 1177749-58-4 | Details |
| (3R,3aS,6aR)-Hydroxyhexahydrofuro[2,3-β]furanyl Succinimidyl Carbonate | C11H13NO7 | 253265-97-3 | Details |
| Clofarabine Impurity 1 | C26H21FO7 | 704916-12-1 | Details |
| Clarithromycin EP Impurity L | C38H70N2O13 | 127253-05-8 | Details |
| Clarithromycin EP Impurity M | C37H68N2O13 | 127182-43-8 | Details |
| Pregnanolone | C21H34O2 | 128-20-1 | Details |
| USP25 and 28 inhibitor AZ-2 | C17H17BrF3NO3 | 2165322-95-0 | Details |
| Sialylglycopeptide | C112H189N15O70 | 189035-43-6 | Details |
| Timapiprant sodium | C21H18FN2NaO2 | 950688-14-9 | Details |
| S(-)-N,N-dimethyl-1-ferrocenylethylamine | C14H19FeN10* | 31886-57-4 | Details |
| Centaureidin | C18H16O8 | 17313-52-9 | Details |
| Tert-butyl 3-oxomorpholine-4-carboxylate | C9H15NO4 | 142929-48-4 | Details |
| Clarithromycin EP Impurity F | C39H71NO13 | 128940-83-0 | Details |
| AX20017 | C13H16N2O2S | 329221-38-7 | Details |
| F-15599 | C19H21ClF2N4O | 635323-95-4 | Details |
| CBP-IN-1 | C30H32F2N4O3 | 2222941-37-7 | Details |
| DMNQ | C12H10O4 | 6956-96-3 | Details |
| BMS-1166 hydrochloride | C36H34Cl2N2O7 | 2113650-05-6 | Details |
| Phaseoloidin | C14H18O9 | 118555-82-1 | Details |
| 5-Methoxycarbonylsalicylamide | C9H9NO4 | 63874-38-4 | Details |
| AT-007 | C17H10F3N3O3S2 | 2170729-29-8 | Details |
| Product Total： Product Page： | ||||
| 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 | ||||